DNDN
Dendreon Corporation
Biotechnology company developing immunotherapy for prostate cancer
CUSIP: 24823Q107HealthcareUS1 holder
Dendreon Corporation
Biotechnology company developing immunotherapy for prostate cancer
No financial data available for this security.